- $381.92m
 - $340.48m
 - $6.03m
 
- 46
 - 52
 - 62
 - 53
 
Annual balance sheet for Anterix, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st  | 2022 March 31st  | 2023 March 31st  | 2024 March 31st  | 2025 March 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 118 | 106 | 43.2 | 60.6 | 47.4 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.004 | 0.238 | 0.418 | 9.1 | 10.2 | 
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 121 | 116 | 59.5 | 73 | 60.8 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8.67 | 7 | 6.98 | 6.49 | 6.13 | 
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 253 | 278 | 279 | 325 | 333 | 
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.62 | 9.64 | 31.9 | 18 | 27.2 | 
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 40.5 | 91.7 | 98.8 | 164 | 177 | 
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 213 | 186 | 180 | 161 | 157 | 
| Total Liabilities & Shareholders' Equity | 253 | 278 | 279 | 325 | 333 | 
| Total Common Shares Outstanding |